ORIGINAL RESEARCH article

Front. Immunol.

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1648139

This article is part of the Research TopicFormation and Remodeling of Immunological Niches in Tumors: Organ-Specific Mechanisms and Inflammatory Parallels: Volume IIView all 7 articles

Mechanistic insights into promotion of non-small cell lung cancer by BAG5 using integrative multi-omics approaches

Provisionally accepted
Jingshan  HuangJingshan Huang1,2Jia-mei  WangJia-mei Wang2,3Ye  YuanYe Yuan2,4Ting  ZhangTing Zhang2Bai-Qiang  LiBai-Qiang Li2Fu-Ying  ZhaoFu-Ying Zhao2Liang  HaoLiang Hao2Zhan-Wu  YuZhan-Wu Yu4Hua-Qin  WangHua-Qin Wang2*
  • 1Shengjing Hospital of China Medical University, Shenyang, China
  • 2China Medical University, Shenyang, China
  • 3The First Hospital of China Medical University, Shenyang, China
  • 4Liaoning Cancer Hospital and Institute, Shenyang, China

The final, formatted version of the article will be published soon.

With the continuous emergence of new technologies in omics, the integrative analysis of multi-omics data has become a new direction to explore life mechanisms.The Bcl-2 associated anthanogene (BAG) family is a family of co-chaperones involved in a variety of cellular processes, such as stress signaling, cell cycle and tumorigenesis. BAG5 is the only member of the BAG family that has multiple BAG domains, and its function in non-small cell lung cancer (NSCLC) is largely unknown.Here, we employed a multi-omics approach integrating single cell transcriptomics, proteomics, interactomics, and phosphorproteomics data to obtain a more comprehensive picture of BAG5 function in NSCLC. Based on the multi-omics data and functional analysis using cell lines and patient derived organoid (PDO), the current study demonstrated that BAG5 was involved in regulation of RNA metabolism, mitochondrial dynamics and metabolic reprogramming, as well as cytoskeleton and EMT to promote proliferation and invasion of NSCLC, underscoring its potential role in NSCLC. Our findings provide evidence that BAG5 exerts its oncogenic effects via multiple pathways, which can be exploited as a potential therapeutic target for NSCLC.

Keywords: 2 BAG5, NSCLC, multi-omics, metabolic reprogramming, EMT

Received: 16 Jun 2025; Accepted: 11 Jul 2025.

Copyright: © 2025 Huang, Wang, Yuan, Zhang, Li, Zhao, Hao, Yu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Hua-Qin Wang, China Medical University, Shenyang, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.